#Diabetes #insulin #drugdiscovery #innovation #medicine #clinicaltrials #genetic #drugdevelopment #drugdelivery To view or add a comment, sign in A class of diabetes drugs called GLP-1 receptor agonists works by directly stimulating the pancreas to release more insulin, which lowers blood sugar
Adipose tissue
Semaglutide (Wegovy/Ozempic) is the closest FDA-approved alternative, targeting the GLP-1 receptor that tirzepatide also activates
Should such entrustment become necessary in the future, the Company will notify users of the entrusted party and the scope of the entrusted tasks, and obtain prior consent when required
In SURMOUNT-1, 72 weeks of tirzepatide induced mean WL of 1622.5% in people without diabetes compared to 2.4% with placebo, with no sign of the weight plateauing, suggesting that there may be further WL with long-term use [46]
Just a convenient way to access medical weight loss support through an online evaluation